NICE recommends the use of the Oncotype DX® test to help guide chemotherapy decision
United Kingdom
Brazil
Canada - English
Canada - Français
Deutschland
France
Ελλάδα
Ireland
Latin America
Netherlands
Spain
Switzerland
United States
日本
International
Physician Login
  • Healthcare Professionals
    • Oncotype DX Breast Recurrence Score
    • About the test
    • Value in clinical practice
      • Node-negative
      • Node-positiveNEW DATA
    • Evidence it works
      • Node-negative
      • Node-positive
    • How does it compare to other tests?
    • Prognostic vs. Predictive
    • Whom to test
    • Interpreting the results
    • How to order a test
    • Case studies NEW
    • Videos and webcasts
  • Patients and Carers
    • About the test
    • Eligibility and testing
    • Oncotype DX Results: What to expect
    • FAQs and useful resources
  • Press Room
  • Contact Us
×

This webpage is intended to be viewed by UK Healthcare Professionals only and not by members of the public.

I'm a Healthcare Professional
For Patients
Healthcare Professionals > Oncotype DX Breast Recurrence Score
  • Topics

Share

  • About the test
  • Value in clinical practice
    • Node-negative
    • Node-positiveNEW DATA
  • Evidence it works
    • Node-negative
    • Node-positive
  • How does it compare to other tests?
  • Prognostic vs. Predictive
  • Whom to test
  • Interpreting the results
  • How to order a test
  • Case studies NEW
  • Videos and webcasts

Contact Us

GET IN TOUCH
follow us
×

You are now leaving this site. Any third party link you select from this site may take you to an Exact Sciences website intended for US audiences or a website that is not affiliated with Exact Sciences.

I Agree
  • Healthcare Professionals
    • About the test
    • Value in clinical practice
      • Node-Negative
      • Node-positive
    • Evidence it works
      • Node-negative
      • Node-positive
    • How does it compare to other tests
    • Prognostic vs. Predictive
    • Whom to test
    • Interpreting the results
    • How to order a test
  • Patients and Carers
    • About the test
    • Eligibility and testing
    • Oncotype DX test results
    • FAQs and useful resources
  • Home
  • Licenses
  • IVDR CE Certificate Oncotype DX
  • Privacy Policy
  • Terms & Conditions
  • Worldwide Websites

Copyright © 2004-2025 Genomic Health, Inc. All Rights Reserved.

In the US and certain other jurisdictions, Genomic Health, Oncotype DX, Oncotype IQ, Recurrence Score, Oncotype DX Breast Recurrence Score, and Oncotype DX Colon Recurrence Score are registered trademarks, and "Making cancer care smarter" is a pending registered trademark of Genomic Health, Inc. Exact Sciences is a registered trademark of Exact Sciences Corporation.

×